The Preserflo MicroShunt glaucoma drainage system is intended to reduce intraocular pressure (IOP) in the eyes of patients with primary open-angle glaucoma where IOP remains uncontrollable while on maximum tolerated medical therapy and/or where glaucoma progression warrants surgery.
It measures 8.5 mm in length and is made from a uniquely biocompatible material called SIBS – Poly(styrene-block-isobutylene-block-styrene). SIBS has been safely used in cardiac stent coating for over 15 years.
The Preserflo MicroShunt’s size, shape, and fin help keep the device stable and securely in place, and it is designed to resist degradation over time. The procedure is less invasive than traditional glaucoma surgeries.1
In the pivotal study, the majority (72%) of Preserflo MicroShunt patients were medication-free at 12 months.1 The study also found that compared with traditional glaucoma surgeries, Preserflo MicroShunt may result in fewer complications after surgery.1
Contact: Glaukos Account Manager
Reference
- Baker D., Barneby H., Moster M., et al., Ab externo microshunt versus trabeculectomy in primary open-angle glaucoma. Ophthalmology. May 2021, DOI: doi.org/10.1016/j.ophtha.2021.05.023.
